Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01884740
Title Phase I/II Trial Of Super-Selective Intraarterial Infusion Of Erbitux and Bevacizumab For Treatment Of Relapsed/Refractory Intracranial Glioma In Patients Under 22 Years Of Age
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Weill Medical College of Cornell University
Indications

malignant astrocytoma

oligodendroglioma

glioblastoma

brain stem glioma

Therapies

Bevacizumab + Cetuximab

Age Groups: child
Covered Countries USA


No variant requirements are available.